The quarter missed a low but positive earnings bar. Available published estimates for Q2 adjusted EPS ranged roughly from $0.10 to $0.20, while Sylvamo delivered just $0.03; reported EPS was a $0.28 loss. The comparison is imperfect because the filing’s adjusted measure excludes special items and foreign-exchange effects, but either way the result was materially below expectations. (Adjusted Operating Earnings Per Share)
| Metric | Q2 2026 | Q1 2026 | Q2 2025 | Read-through |
|---|---|---|---|---|
| Net sales | $806M | $755M | $794M | Up sequentially and modestly year over year (Financial Highlights) |
| Adjusted operating earnings | $1M | $(21)M | $15M | Recovered from Q1, but below last year (Adjusted Operating Earnings reconciliation) |
| Adjusted operating EPS | $0.03 | $(0.53) | $0.37 | Well below available $0.10–$0.20 published estimates (Adjusted Operating Earnings Per Share) |
| Adjusted EBITDA | $60M | $29M | $82M | Sequential improvement, but down 27% year over year (Adjusted EBITDA reconciliation) |
| Free cash flow | $(23)M | $(59)M | $(2)M | Still negative despite improvement from Q1 (Free Cash Flow) |
Operations improved sequentially, but not enough to change the underlying earnings picture. Business segment operating profit rose to $14 million from a $15 million loss in Q1, led by North America improving to $50 million from $25 million. Europe’s loss narrowed to $20 million from $44 million, but Latin America swung to a $16 million loss from $4 million of profit. Against Q2 2025, total segment profit still fell by more than half, with all three regions below the prior-year operating result except for the sequential North America recovery. (Operating Profit by Business Segment)
Revenue was better than the recent run rate, but margin conversion remained weak. Sales rose to $806 million from $755 million in Q1 and were slightly above Q2 2025, yet adjusted EBITDA margin was only 7% versus 10% last year. That gap shows the price increases and improved North American conditions had not yet translated into comparable profitability, while planned outages, higher input costs, tariffs, imports, and the Riverdale transition remained meaningful offsets. (Adjusted EBITDA Margin; Management Summary; Operating Profit by Business Segment)
Cash generation and leverage add a second negative signal. Free cash flow was negative $23 million in the quarter and negative $82 million for the first half versus negative $27 million a year earlier. First-half capital spending was $110 million, while total debt increased to $964 million from $853 million at year-end; cash fell to $123 million from $135 million. Management expects most free cash flow in the second half, but the filing provides no numeric cash-flow guidance to offset the current shortfall. (Free Cash Flow; Cash Flow statement; Balance Sheet)
Net: a sequential recovery, but a clear miss versus the market’s earnings expectation. The filing confirms that the transition year is progressing operationally, especially in North America, but the reported profit, adjusted EPS, year-over-year EBITDA decline, and negative free cash flow leave the overall message worse than expected rather than merely in line.
Read the original 8-K on SEC EDGAR ↗